Table 4.

PCOS phenotypes in the studied subpopulations of PCOS women.

TSH > 2.5 and positive anti-thyroid antibodies (n = 16, N = 367)
Variable	% n	% N-n	p
Phenotype A	50% (8)	52% (182)	0.88
Phenotype B	37% (6)	34% (121)	0.80
Phenotype C	6.5% (1)	5% (17)	0.80
Phenotype D	6.5% (1)	9% (31)	0.7
TSH > 2.5 and negative anti-thyroid antibodies (n = 98, N = 367)
Variable	% n	% N-n	p
Phenotype A	52% (52)	51% (138)	0.95
Phenotype B	34% (34)	35% (93)	0.88
Phenotype C	5% (5)	5% (13)	0.95
Phenotype D	9% (9)	9% (23)	0.9
TSH > 2.5 regardless anti-thyroid antibodies (n = 114, N = 367)
Variable	% n	% N-n	p
Phenotype A	52% (60)	52% (130)	0.99
Phenotype B	35% (40)	35% (87)	0.95
Phenotype C	5% (6)	5% (12)	0.93
Phenotype D	8% (9)	8% (22)	0.96
TSH ≤ 2.5 and positive anti-thyroid antibodies (n = 28, N = 367)
Variable	% n	% N-n	p
Phenotype A	50% (14)	52% (176)	0.84
Phenotype B	32% (9)	35% (118)	0.77
Phenotype C	7% (2)	5% (16)	0.59
Phenotype D	11% (3)	8% (29)	0.7
TSH ≤ 2.5 and negative anti-thyroid antibodies (n = 225, N = 367)
Variable	% n	% N-n	p
Phenotype A	52% (116)	51.5% (74)	0.9
Phenotype B	35% (78)	34% (49)	0.85
Phenotype C	4.5% (10)	5.5% (8)	0.64
Phenotype D	8.5% (19)	9% (13)	0.86
Presence of anti-thyroid antibodies regardless of TSH (n = 44, N = 367)
Variable	% n	% N-n	p
Phenotype A	50% (22)	52% (168)	0.80
Phenotype B	34% (15)	34% (112)	0.93
Phenotype C	7% (3)	5% (15)	0.54
Phenotype D	9% (4)	9% (28)	0.92